DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Choi D, Kim YS, Kim MJ , et al.
A phase 2, multidose, double-blind, randomized, multicenter, comparative study of zabofloxacin vs moxifloxacin in the treatment of mild to moderate community-acquired pneumonia [abstract].
Presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, September 9–12, 2012, San Francisco, California, L1–L294
We do not assume any responsibility for the contents of the web pages of other providers.